Moderator: Zoher Ghogawala, MD, FACS
206. Does ACR result in greater morbidity than LLIF alone when treating adult spinal deformity?
Robert K. Eastlack, MD1; Juan S. Uribe, MD2; Richard G. Fessler, MD, PhD3; Khoi D. Than, MD4; Stacie Tran, MPH5; Dean Chou, MD6; Paul Park, MD7; Kai-Ming G. Fu, MD, PhD8; Michael Y. Wang, MD9; Adam S. Kanter, MD10; David O. Okonkwo, MD11; Pierce D. Nunley, MD12; Gregory M. Mundis Jr., MD13; International Spine Study Group14
1Scripps Clinic, San Diego, CA, US; 2Barrow Neurological Institute, Phoenix, AZ, US; 3Rush University Medical Center, Dept of Neuro Surgery, Chicago, IL, US; 4Oregon Health & Science University, Portland, OR, US; 5San Diego Spine Foundation, San Diego, CA, US; 6University of California San Francisco, San Francisco, CA, US; 7University Of Michigan - Dept of Neurosurgery, Ann Arbor, MI, US; 8Weill Cornell Medicine/NewYork Presbyterian, New York, NY, US; 9University of Miami, Dept of Neurosurgery, Miami, FL, US; 10UPMC-Presbyterian/Dept of Neurological Surgery, Pittsburgh, PA, US; 11Pittsburgh, PA, US; 12Spine Institute of Louisiana, Shreveport, LA, US; 13Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 14Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
207. Two and three year outcomes of minimally invasive and hybrid correction of adult spinal deformity
Robert K. Eastlack, MD1; Richard G. Fessler, MD, PhD2; Khoi D. Than, MD3; Stacie Tran, MPH4; Dean Chou, MD5; Andrew K. Chan, MD6; Kai-Ming G. Fu, MD, PhD7; Paul Park, MD8; Michael Y. Wang, MD9; Adam S. Kanter, MD10; David O. Okonkwo, MD11; Pierce D. Nunley, MD12; Juan S. Uribe, MD13; Gregory M. Mundis Jr., MD14; International Spine Study Group15
1Scripps Clinic, San Diego, CA, US; 2Rush University Medical Center, Dept of Neuro Surgery, Chicago, IL, US; 3Oregon Health & Science University, Portland, OR, US; 4San Diego Spine Foundation, San Diego, CA, US; 5University of California San Francisco, San Francisco, CA, US; 6Department of Neurological Surgery, UCSF, San Francisco, CA, US; 7Weill Cornell Medicine/NewYork Presbyterian, New York, NY, US; 8University Of Michigan - Dept of Neurosurgery, Ann Arbor, MI, US; 9University of Miami, Dept of Neurosurgery, Miami, FL, US; 10UPMC-Presbyterian/Dept of Neurological Surgery, Pittsburgh, PA, US; 11Pittsburgh, PA, US; 12Spine Institute of Louisiana, Shreveport, LA, US; 13Barrow Neurological Institute, Phoenix, AZ, US; 14Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 15Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
208. Predictors of superior recovery kinetics in adult cervical deformity correction: an analysis using a novel area under the curve methodology
Katherine E. Pierce, BS1; Peter G. Passias, MD2; Renaud Lafage, MSc3; Virginie Lafage, PhD3; Douglas C. Burton, MD4; Robert A. Hart, MD5; D. Kojo Hamilton, MD6; Jeffrey L. Gum, MD7; Justin K. Scheer, MD8; Alan H. Daniels, MD9; Shay Bess, MD10; Daniel M. Sciubba, MD16; Alexandra Soroceanu, MD, MPH11; Eric O. Klineberg, MD12; Christopher I. Shaffrey, MD13; Breton Line, BS14; Frank J. Schwab, MD3; Justin S. Smith, MD, PhD15; Christopher P. Ames, MD8; International Spine Study Group16
1New York, NY, US; 2NY Spine Institute, NYU Langone Health, New York, NY, US; 3Hospital for Special Surgery, New York, NY, US; 4University of Kansas Medical Center, Kansas City, KS, US; 5Swedish Neuroscience Institute, Seattle, WA, US; 6University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 7Norton Leatherman Spine Center, Louisville, KY, US; 8University of California, San Francisco, San Francisco, CA, US; 9Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 10Denver, CO, US; 11University of Calgary, Calgary, Canada; 12UC, Davis School of Medicine, Sacramento, CA, US; 13University of Virginia, Charlottesville, VA, US; 14Denver International Spine Center, Denver, CO, US; 15UVA Health System, Charlottesville, VA, US; 16Brighton, CO, US; 16John Hopkins University, School of Medicine
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
209. Global spinal deformity from the upper cervical perspective: what is "abnormal" in the upper cervical spine?
Peter G. Passias, MD1; Haddy Alas, BS2; Renaud Lafage, MSc3; Bassel G. Diebo, MD4; Christopher P. Ames, MD5; Paul Park, MD6; Khoi D. Than, MD7; Alan H. Daniels, MD8; D. Kojo Hamilton, MD9; Douglas C. Burton, MD10; Robert A. Hart, MD11; Shay Bess, MD12; Breton Line, BS13; Eric O. Klineberg, MD14; Christopher I. Shaffrey, MD15; Justin S. Smith, MD, PhD16; Frank J. Schwab, MD3; Virginie Lafage, PhD3; International Spine Study Group17
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3Hospital for Special Surgery, New York, NY, US; 4Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 5University of California, San Francisco, San Francisco, CA, US; 6University Of Michigan - Dept of Neurosurgery, Ann Arbor, MI, US; 7Oregon Health & Science University, Portland, OR, US; 8Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 9University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 10University of Kansas Medical Center, Kansas City, KS, US; 11Swedish Neuroscience Institute, Seattle, WA, US; 12Denver, CO, US; 13Denver International Spine Center, Denver, CO, US; 14UC, Davis School of Medicine, Sacramento, CA, US; 15University of Virginia, Charlottesville, VA, US; 16UVA Health System, Charlottesville, VA, US; 17Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion
210. Comparing and contrasting the clinical utility of sagittal spine alignment classification frameworks: Roussouly versus SRS-Schwab
Peter G. Passias, MD1; Cole Bortz, BA2; Renaud Lafage, MSc3; Bassel G. Diebo, MD4; Virginie Lafage, PhD3; Christopher P. Ames, MD5; Douglas C. Burton, MD6; Robert A. Hart, MD7; Munish C. Gupta, MD8; Daniel M. Sciubba, MD9; Shay Bess, MD10; Richard A. Hostin Jr., MD11; Christopher I. Shaffrey, MD12; Breton Line, BS13; Eric O. Klineberg, MD14; Justin S. Smith, MD, PhD15; Frank J. Schwab, MD3; International Spine Study Group16
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2New York, NY, US; 3Hospital for Special Surgery, New York, NY, US; 4Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 5University of California, San Francisco, San Francisco, CA, US; 6University of Kansas Medical Center, Kansas City, KS, US; 7Swedish Neuroscience Institute, Seattle, WA, US; 8Washington University School of Medicine, St. Louis, MO, US; 9John Hopkins University/School of Medicine, Baltimore, MD, US; 10Denver, CO, US; 11Southwest Scoliosis Institute, Plano, TX, US; 12University of Virginia, Charlottesville, VA, US; 13Denver International Spine Center, Denver, CO, US; 14UC, Davis School of Medicine, Sacramento, CA, US; 15UVA Health System, Charlottesville, VA, US; 16Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
211. Defining a surgical invasiveness threshold for major complications following adult spinal deformity surgery
Brian J. Neuman, MD1; Andrew B. Harris, BS2; Eric O. Klineberg, MD3; Richard A. Hostin Jr., MD4; Themistocles S. Protopsaltis, MD5; Peter G. Passias, MD6; Jeffrey L. Gum, MD7; Robert A. Hart, MD8; Michael P. Kelly, MD9; Alan H. Daniels, MD10; Christopher P. Ames, MD11; Christopher I. Shaffrey, MD12; Khaled M. Kebaish, MD13; International Spine Study Group14
1Baltimore, MD, US; 2Johns Hopkins Hospital, Baltimore, MD, US; 3UC, Davis School of Medicine, Sacramento, CA, US; 4Southwest Scoliosis Institute, Plano, TX, US; 5Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 6NY Spine Institute, NYU Langone Health, New York, NY, US; 7Norton Leatherman Spine Center, Louisville, KY, US; 8Swedish Neuroscience Institute, Seattle, WA, US; 9Washington University, Saint Louis, MO, US; 10Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 11University of California, San Francisco, San Francisco, CA, US; 12University of Virginia, Charlottesville, VA, US; 13Johns Hopkins University, Baltimore, MD, US; 14Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
212. Giving patients the info they want: practical answers to FAQs for shared decision making in ASD surgery
Jeffrey L. Gum, MD1; Alexandra Soroceanu, MD, MPH2; Miquel Serra-Burriel, PhD3; Breton Line, BS4; Themistocles S. Protopsaltis, MD5; Richard A. Hostin Jr., MD6; Peter G. Passias, MD7; Michael P. Kelly, MD8; Douglas C. Burton, MD9; Justin S. Smith, MD, PhD10; Christopher I. Shaffrey, MD11; Virginie Lafage, PhD12; Renaud Lafage, MSc12; Eric O. Klineberg, MD13; Han Jo Kim, MD12; Andrew B. Harris, BS14; Khaled M. Kebaish, MD15; Frank J. Schwab, MD12; Shay Bess, MD16; Christopher P. Ames, MD17; International Spine Study Group18
1Norton Leatherman Spine Center, Louisville, KY, US; 2University of Calgary, Calgary, Canada; 3Barcelona, Spain; 4Denver International Spine Center, Denver, CO, US; 5Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 6Southwest Scoliosis Institute, Plano, TX, US; 7NY Spine Institute, NYU Langone Health, New York, NY, US; 8Washington University, Saint Louis, MO, US; 9University of Kansas Medical Center, Kansas City, KS, US; 10UVA Health System, Charlottesville, VA, US; 11University of Virginia, Charlottesville, VA, US; 12Hospital for Special Surgery, New York, NY, US; 13UC, Davis School of Medicine, Sacramento, CA, US; 14Johns Hopkins Hospital, Baltimore, MD, US; 15Johns Hopkins University, Baltimore, MD, US; 16Denver, CO, US; 17University of California, San Francisco, San Francisco, CA, US; 18Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
213. Adult spinal deformity patients with a decline in certain activities of daily living are likely to fail nonoperative treatment
Andrew B. Harris, BS1; Brian J. Neuman, MD2; Richard A. Hostin Jr., MD3; Alexandra Soroceanu, MD, MPH4; Themistocles S. Protopsaltis, MD5; Peter G. Passias, MD6; Jeffrey L. Gum, MD7; Munish C. Gupta, MD8; Michael P. Kelly, MD9; Eric O. Klineberg, MD10; Virginie Lafage, PhD11; Douglas C. Burton, MD12; Shay Bess, MD13; Khaled M. Kebaish, MD14; International Spine Study Group15
1Johns Hopkins Hospital, Baltimore, MD, US; 2Baltimore, MD, US; 3Southwest Scoliosis Institute, Plano, TX, US; 4University of Calgary, Calgary, Canada; 5Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 6NY Spine Institute, NYU Langone Health, New York, NY, US; 7Norton Leatherman Spine Center, Louisville, KY, US; 8Washington University School of Medicine, St. Louis, MO, US; 9Washington University, Saint Louis, MO, US; 10UC, Davis School of Medicine, Sacramento, CA, US; 11Hospital for Special Surgery, New York, NY, US; 12University of Kansas Medical Center, Kansas City, KS, US; 13Denver, CO, US; 14Johns Hopkins University, Baltimore, MD, US; 15Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
214. Adult spinal deformity surgery does not prevent return to work among employed patients but more invasive surgery may delay the return
Brian J. Neuman, MD1; Andrew B. Harris, BS2; Richard A. Hostin Jr., MD3; Micheal Raad, MD1; Themistocles S. Protopsaltis, MD4; Christopher P. Ames, MD5; Peter G. Passias, MD6; Jeffrey L. Gum, MD7; Munish C. Gupta, MD8; Eric O. Klineberg, MD9; Robert A. Hart, MD10; Douglas C. Burton, MD11; Shay Bess, MD12; International Spine Study Group13; Khaled M. Kebaish, MD14
1Baltimore, MD, US; 2Johns Hopkins Hospital, Baltimore, MD, US; 3Southwest Scoliosis Institute, Plano, TX, US; 4Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 5University of California, San Francisco, San Francisco, CA, US; 6NY Spine Institute, NYU Langone Health, New York, NY, US; 7Norton Leatherman Spine Center, Louisville, KY, US; 8Washington University School of Medicine, St. Louis, MO, US; 9UC, Davis School of Medicine, Sacramento, CA, US; 10Swedish Neuroscience Institute, Seattle, WA, US; 11University of Kansas Medical Center, Kansas City, KS, US; 12Denver, CO, US; 13Brighton, CO, US; 14Johns Hopkins University, Baltimore, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion